Victoria Blinder - Concepedia

Author

Victoria Blinder

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Ballman, Karla V, Blinder, V.S, Blinder, Victoria S, Blinder, Victoria S., Switzerland Bleicher, V Blinder, V. Blinder, V. S. Blinder, V.S. Blinder, Victoria Blinder

176

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University University of North Carolina at Chapel Hill Brigham and Women's Hospital American Society of Clinical Oncology

About

Victoria Blinder is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1.7K
2	Public Health	7	7	513
3	Health Sciences	6	6	1K
4	Nursing	5	5	478
5	Social Sciences	3	3	343

Victoria Blinder

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) Jonas A. de Souza, Bonnie J. Yap, Kristen Wroblewski, Cancer Quality Of LifeCancer ManagementClinical EndpointComprehensive ScoreBackground Cancer	2016	819
Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer Ethan Basch, Deborah Schrag, Sydney Henson, JAMA	2022	337
American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority Populations Jennifer J. Griggs, Shail Maingi, Victoria Blinder, Journal of Clinical Oncology Family MedicineCancer Care ContinuumHealth Care DisparityCancer ManagementAmerican Society	2017	249
Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0 Sara M. Tolaney, Elizabeth Garrett‐Mayer, Julia White, Journal of Clinical Oncology	2021	192
Return to work in low‐income Latina and non‐Latina white breast cancer survivors: A 3‐year longitudinal study Victoria Blinder, Sujata Patil, Amardeep Thind, Cancer	2011	104
Women With Breast Cancer Who Work For Accommodating Employers More Likely To Retain Jobs After Treatment Victoria Blinder, Carolyn Eberle, Sujata Patil, Health Affairs EthnicityHealth Care DisparityBreast OncologyDiscriminationHealth Disparities	2017	99
A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients Ting Bao, Andrew D. Seidman, Lauren Piulson, European Journal of Cancer Pain TherapyPain ResearchHealth SciencesBreast Cancer PatientsAlternative Medicine	2018	95
Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer Heather T. Gold, Michael J. Hall, Victoria Blinder, Cancer	2009	84
Employment After a Breast Cancer Diagnosis: A Qualitative Study of Ethnically Diverse Urban Women Victoria Blinder, Madhuvanti M. Murphy, Linda T. Vahdat, Journal of Community Health EthnicityHealth Care DisparityGender StudiesBlack WomenAfrican American Studies	2011	74
Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study Victoria Blinder, Sujata Patil, Carolyn Eberle, Breast Cancer Research and Treatment NursingBreast OncologyCancer Epidemiology5-Year Longitudinal StudyMedicine	2013	71

Page 1